Loading...
Challenges Enrolling Patients with Acute Ischemic Stroke into Cell Therapy Trials
Infusion of autologous bone marrow-derived mononuclear cells (MNCs) is a promising investigational therapeutic approach for patients with acute ischemic stroke. Preclinical models indicate that MNCs can reduce neurological deficits and enhance recovery. We recently concluded a phase I clinical trial...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Mary Ann Liebert, Inc.
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3528085/ https://ncbi.nlm.nih.gov/pubmed/22970907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2012.0404 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|